Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × ioflupane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Disease 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03185182 2019-06-21

RCCSCAN

Region Skane

Phase 2 Terminated

5 enrolled 5 charts

Carcinoma, Renal Cell, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡